Vascular reactivity changes in glucose-intolerant rat

Journal of Cardiovascular Pharmacology

Volumn 50, Issue 5, 2007, Pages 590-597

  Abebe, Worku ^a   Mozaffari, Mahmood S ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Aorta; Glucose intolerance; Neonatal rat; Prediabetes; Strepotozoticin; Vascular responses

Indexed keywords

ACETYLCHOLINE; CALCIUM; CALPHOSTIN C; GLUCOSE; NITRIC OXIDE; NORADRENALIN; PHORBOL DIBUTYRATE; PHORBOL ESTER; SEROTONIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENDOTHELIUM; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ANIMALS; ANIMALS, NEWBORN; AORTA; BLOOD GLUCOSE; BODY WEIGHT; CALCIUM; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EGTAZIC ACID; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; MALE; NAPHTHALENES; NG-NITROARGININE METHYL ESTER; NITROPRUSSIDE; NOREPINEPHRINE; PHORBOL 12,13-DIBUTYRATE; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RATS; RATS, INBRED WKY; SEROTONIN; VASOCONSTRICTION; VASODILATION;

EID: 36348942903     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318150d104     Document Type: Article

References (36)

1. Leahy JL. Pathogenesis of type 2 diabetes mellitus. Arch Med Res. 2005;36:197-209.
2. Centers for Disease Control and Prevention. Number of Americans with diabetes continues to increase. Media Relations. 2005;26.
3. Kaufman FR. Type 2 diabetes in children and young adults: a "New Epidemic." Clin Diabetes. 2002;20:217-224.
4. Varughese GI, Tomson J, Lip GY. Type 2 diabetes mellitus: a cardiovascular perspective. Int J Clin Pract. 2005;59:798-816.
5. Prior JO, Ouinones MJ, Hernandez-Pampaloni M, et al. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation. 2005;11:2291-2298.
6. Subramanian R, MacLeod KM. Age-dependent changes in blood pressure and arterial reactivity in obese Zucker rats. Eur J Pharmacol. 2003;447:143-152.
7. Zemel MB, Reddy S, Sowers JR. Insulin attenuation of vasoconstrictor responses to phenylephrine in Zucker lean and obese rats. Am J Hypertens. 1991;4:537-539.
8. Turner NC, Gudgeon C, Toseland N. Effects of genetic hyperinsulinaemia on vascular reactivity, blood pressure, and renal structure in the Zucker rat. J Cardiovasc Pharmacol. 1995;26:714-720.
9. Cox RH, Kikta DC. Age-related changes in thoracic aorta of obese Zucker rats. Am J Physiol. 1992;262:H1548-H1556.
10. 2+ handling in the aorta of Zucker obese rats with insulin resistance. Diabetes. 1996;45(Suppl 3):S55-S58.
11. Kamata K, Yamashita K. Insulin resistance and impaired endothelium-dependent renal vasodilatation in fructose-fed hypertensive rats. Res Commun Mol Path Pharmacol. 1999;103:195-210.
12. Verma S, Bhanot S, Yao L, et al. Defective endothelium-dependent relaxation in fructose-hypertensive rats. Am J Hypertens. 1996;9:370-376.
13. Katakam PVG, Ujhelyi MR, Miller AW. EDHF-mediated relaxation is impaired in fructose-fed rats. J Cardiovasc Pharmacol. 1999;34:461-467.
14. Schaffer SW, Mozaffari MS. The neonatal STZ model of diabetes. In: McNeill, JH, ed. Experimental Models of Diabetes. Boca Raton, FL: CRC Press; 1999:231-255.
15. Mozaffari MS, Patel C, Warren BK, et al. NaCl-induced hypertensive rat model of non-insulin-dependent diabetes: role of sympathetic modulation. Am J Hypertens. 2000;13:540-546.
16. Mozaffari MS, Schaffer SW. Chronic taurine treatment ameliorates reduction in saline-induced diuresis and natriuresis. Kid Int. 2002;61:1750-1759.
17. Mozaffari MS, Schaffer SW. Impaired saline-stimulated diuresis and natriuresis in the conscious hypertensive glucose-intolerant rat. Am J Hypertens. 2002;15:58-65.
18. Arulmozhi DK, Veeranjaneyulu A, Bodhankar SL. Neonatal streptozotocin-induced rat model of Type 2 diabetes mellitus: A glance. Indian J Pharmacol. 2004;36:217-221.
19. Abebe W, Mozaffari MS. Taurine depletion alters vascular reactivity in rats. Can J Physiol Pharmacol. 2003;81:903-909.
20. Maddux WF, Abebe W, Schuster GS, et al. Effects of dental resin components on vascular reactivity. J Biomed Mater Res. 2002;61:572-580.
21. 1-adrenoceptor stimulation in the absence and presence of extracellular calcium. J Cardiovac Pharmacol. 1990;16:239-248.
22. Abebe W, MacLeod KM. Protein kinase C-mediated contractile responses of arteries from diabetic rats. Br J Pharmacol. 1990;101:465-473.
23. Weber L, Chow W, Moshenko J, et al. Phramacological inverstgation of signaling mechanisms contributing to phasic and tonic components of contractile response of rat arteries to noradrenaline. Can J Physiol Pharmacol. 1995;73:594-601.
24. Weber L, Chow W, Abebe W, et al. Enhanced contractile responses of arteries from streptozotocin diabetic rats to sodium fluoride. Br J Pharmacol. 1996;118:115-122.
25. Mueed I, Zhang L, MacLeod KM. Role of the PKC/CPI-17 pathway in enhanced contractile responses of mesenteric arteries from diabetic rats to a-adrenoceptor stimulation. Br J Pharmacol. 2005;146:972-982.
26. Abebe W, Hussain T, Olanrewaju H, et al. Role of nitric oxide in adenosine receptor-mediated relaxation of porcine coronary artery. Am J Physiol. 1995;269:H1672-H1678.
27. Abebe W, Mozaffari MS. Effect of taurine deficiency on adenosine receptor-mediated relaxation of the rat aorta. Vascul Pharmacol. 2003;40:219-228.
28. Abebe W, Cavallari N, Agrawal DK, et al. Functional and morphological assessment of rat aorta stored in University of Wisconsin and Eurocollins solutions. Transplantation. 1993;56:808-816.
29. Nagareddy P, Xia Z, MacLeod KM, et al. N-acetylcysteine prevents nitrosative stress-associated depression of blood pressure and heart rate in streptozotocin diabetic rats. J Cardiovasc Pharmacol. 2006;47:513-520.
30. Fitzgerald SM, Brands MW. Nitric oxide may be required to prevent hypertension at the onset of diabetes. Am J Physiol. 2000;279:E762-E768.
31. Akbar H, Chen NY, Fossen DV, et al. Increased vascular contractile sensitivity to serotonin in spontaneously hypertensive rats is linked with increased turnover of phosphoinositide. Life Sci. 1989;45:577-583.
32. Banes A, Florian JA, Watts SW. Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle. J Pharmacol Exp Ther. 1999;291:1179-1187.
33. Banes A, Watts SW. Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension. BMC Pharmacol. 2003;3:1-15.
34. Kobahyashi E, Nakano H, Morimoto M, et al. (UCN-1028C), a novel microbial compound, is a highly potent specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1989;159:548-553.
35. Rastelli VMF, Akamine EH, Oliveira MA, et al. Influence of insulin on the microvascular response to inflammatory mediators in neonatal streptozotocin diabetic rats. Inflamm Res. 2005;54:173-179.
36. Sartoretto JL, Melo GAN, Carvalho MHC, et al. Metformin treatment restores the altered microvascular reactivity in neonatal streptozotocin-induced diabetic rats increasing NOS activity, but not NOS expression. Life Sci. 2005;77:2676-2689.